Granules Pharmaceuticals, Inc.
Granules Pharmaceuticals Inc. (GPI) is a subsidiary of Granules India located in Chantilly, Virginia. It is a US FDA & DEA approved facility with R&D and manufacturing capabilities for low volume oral solid dosage forms. GPI manufactures tablets, capsules, oral solutions, and powders for oral solutions. The company also distributes products under the 'GPI' label and offers a range of complex products including immediate release, modified release, and chewable dosage forms. With a focus on quality and compliance, GPI is dedicated to providing cost-effective pharmaceutical solutions.
Granules Pharmaceuticals, Inc.
Granules Pharmaceuticals Inc. (GPI) is a subsidiary of Granules India located in Chantilly, Virginia. It is a US FDA & DEA approved facility with R&D and manufacturing capabilities for low volume oral solid dosage forms. GPI manufactures tablets, capsules, oral solutions, and powders for oral solutions. The company also distributes products under the 'GPI' label and offers a range of complex products including immediate release, modified release, and chewable dosage forms. With a focus on quality and compliance, GPI is dedicated to providing cost-effective pharmaceutical solutions.
granulespharma.com
3701 CONCORDE PKY Chantilly, Virginia 20151, US
Details
Year founded
2014
Revenue
10M-25M
Employees
51-200
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- API & Formulation Development
- Business Development
- Careers
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- pharmaceutical production machinery
- weighing equipment
- blending equipment
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that granules pharmaceuticals is ramping up production.
Target industries
Employees working in Granules Pharmaceuticals, Inc.
News
Granules gets USFDA nod for generic gout medication
Granules gets USFDA nod for generic gout medication
Granules Pharmaceuticals, Inc, a wholly-owned foreign subsidiary of the company, has received approval from the US Food & Drug Administration (USFDA) for...
Locations (1)
Granules Pharmaceuticals, Inc.
3701 CONCORDE PKY Chantilly, Virginia 20151, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Granules Pharmaceuticals, Inc. offer?
Granules Pharmaceuticals, Inc. offers a range of services and capabilities, including API & Formulation Development.
What kind of equipment does Granules Pharmaceuticals, Inc. use?
Granules Pharmaceuticals, Inc. uses a variety of equipment, including pharmaceutical production machinery.
What are the target industries of Granules Pharmaceuticals, Inc.?
Granules Pharmaceuticals, Inc. serves several industries, including the medical industry.
How many locations does Granules Pharmaceuticals, Inc. operate?
Granules Pharmaceuticals, Inc. operates from a single location at 3701 concorde parkway, chantilly, virginia 20151, united states.
Where are the headquarters of Granules Pharmaceuticals, Inc.?
The headquarters of Granules Pharmaceuticals, Inc. are located in 3701 concorde parkway, chantilly, virginia 20151, united states.
What is the NAICS code for Granules Pharmaceuticals, Inc.?
The NAICS code for Granules Pharmaceuticals, Inc. is 3254.
How many employees does Granules Pharmaceuticals, Inc. have?
Granules Pharmaceuticals, Inc. has 191 employees.
What is the official website of Granules Pharmaceuticals, Inc.?
The official website of Granules Pharmaceuticals, Inc. is https://granulespharma.com/.
When was Granules Pharmaceuticals, Inc. founded?
Granules Pharmaceuticals, Inc. was founded in 2014.